Partnerships
Our Partnership Focus
Partnering and collaboration such as product licensing, co-development, and co-investment, are crucial for pharmaceutical companies in today’s rapidly evolving market. These partnerships can help companies overcome challenges related to critical aspects of R&D, access to innovative technologies, manufacturing capacity, rising costs, regulatory approvals, and more.
As part of its growth strategy, NovusThera actively seeks out long-term strategic partnerships with innovative and cooperative companies in the complex injectables and pharmaceutical specialty products space. Through these partnerships, the company can combine its strengths and benefits to deliver the best solutions and value to its customers and end-users.
Partnering Areas of Interest
Product co-development and co-investment in quality sterile Injectables and pharmaceutical specialty generics where NovusThera and its partners can accelerate the development process and bring innovative products to the market with greater speed.
Acquiring the marketing rights of successful projects that have demonstrated a proof of concept (POC) and achieved significant milestones.
Product licensing opportunities for late-stage products in both Canada and the US. Specifically, we are seeking to supplement our internal pipeline development in the areas of niche sterile injectables and pharmaceutical specialty generic products.
